SynthesisInternational urology and nephrology2023

Efficacy and safety of tolvaptan versus placebo in the treatment of patients with autosomal dominant polycystic kidney disease: a meta-analysis.

Jingkui Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.